Collegium Pharmaceutical, Inc (COLL) insider trading
Every open-market stock purchase and sale by Collegium Pharmaceutical, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $7.2M over the last 12 months (11 sales). No open-market buys.
- Last insider buy: Paul Brannelly (CFO), $91.8K, 9 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $7.2M (11 sales). Last close $22.91 on Oct 21, 2026.
Recent COLL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 8, 2026 | Gino Santini (Insider) | Bought (not open market) | — |
| May 18, 2026 | John Gordon Freund (Insider) | Sold | $681 |
| May 15, 2026 | John Gordon Freund (Insider) | Sold | $143K |
| May 15, 2026 | John Gordon Freund (Insider) | Bought (not open market) | — |
| May 14, 2026 | John Gordon Freund (Insider) | Bought (not open market) | — |
| May 14, 2026 | Rita J. Balice-Gordon (Insider) | Bought (not open market) | — |
| May 14, 2026 | Carlos V Paya (Insider) | Bought (not open market) | — |
| May 14, 2026 | Nancy Lurker (Insider) | Bought (not open market) | — |
| May 14, 2026 | Gino Santini (Insider) | Bought (not open market) | — |
| May 14, 2026 | Garen G Bohlin (Insider) | Bought (not open market) | — |
| May 14, 2026 | Donovan Michael Glancy (Insider) | Bought (not open market) | — |
| May 13, 2026 | Nancy Lurker (Insider) | Sold | $162K |
| May 11, 2026 | Garen G Bohlin (Insider) | Sold | $323K |
| May 11, 2026 | Garen G Bohlin (Insider) | Bought (not open market) | — |
| Mar 18, 2026 | David Dieter (VP) | Sold | $488K |
| Mar 17, 2026 | David Dieter (VP) | Sold (not open market) | $316K |
| Mar 9, 2026 | David Dieter (VP) | Sold | $228K |
| Mar 3, 2026 | Scott Dreyer (C-suite exec) | Sold | $1.9M |
| Mar 3, 2026 | Scott Dreyer (C-suite exec) | Sold | $146K |
| Feb 10, 2026 | Colleen Tupper (CFO) | Sold (not open market) | $1.2M |
| Feb 10, 2026 | Scott Dreyer (C-suite exec) | Sold (not open market) | $1M |
| Feb 10, 2026 | Colleen Tupper (CFO) | Sold (not open market) | $555K |
| Feb 10, 2026 | Thomas B Smith (C-suite exec) | Sold (not open market) | $539K |
| Feb 10, 2026 | Vikram Karnani (CEO) | Sold (not open market) | $528K |
| Feb 10, 2026 | Scott Dreyer (C-suite exec) | Sold (not open market) | $466K |
Who's trading COLL
- Gino Santini, Director: other filings, last Jun 8, 2026
- John Gordon Freund, Director: sold $143K (2 sales), last May 18, 2026
- Garen G Bohlin, Director: sold $323K (1 sale), last May 14, 2026
- Rita J. Balice-Gordon, Director: sold $172K (1 sale), last May 14, 2026
- Nancy Lurker, Director: sold $162K (1 sale), last May 14, 2026
- Donovan Michael Glancy, Insider: other filings, last May 14, 2026
- Carlos V Paya, Director: other filings, last May 14, 2026
- David Dieter, VP: sold $716K (2 sales), last Mar 18, 2026
- Scott Dreyer, C-suite exec: sold $2.9M (4 sales), last Mar 3, 2026
- Colleen Tupper, CFO: sold $1.2M (2 sales), last Feb 10, 2026
- Vikram Karnani, CEO: other filings, last Feb 10, 2026
- Thomas B Smith, C-suite exec: other filings, last Feb 10, 2026
- John A. Fallon, Insider: sold $1.6M (1 sale), last Nov 12, 2025
Get free alerts when an insider at Collegium Pharmaceutical, Inc files a new trade →